NICOTINE-N-B-GLUCURONIDE
| Title | Journal |
|---|---|
| Liquid chromatography-tandem mass spectrometry method for measurement of nicotine N-glucuronide: a marker for human UGT2B10 inhibition. | Journal of pharmaceutical and biomedical analysis 20110715 |
| Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20100501 |
| Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures. | Clinical chemistry 20081201 |
| Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. | Clinical pharmacology and therapeutics 20080101 |
| Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. | Toxicology letters 20070910 |
| Urinary biomarkers to assess exposure of cats to environmental tobacco smoke. | American journal of veterinary research 20070401 |
| Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites. | Toxicology letters 20050516 |
| N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. | Drug metabolism and disposition: the biological fate of chemicals 20020901 |